This is the authors' abstract. We don't add key points for this paper.
AIM: This study investigates the prophylactic effect of henna on the occurrence of hand-foot syndrome (HFS) in patients receiving capecitabine for breast and colorectal cancer. METHOD: This experimental study was carried out between May 2014 and May 2015. In this self-control experimental study, 52 patients with breast and colorectal cancer were included on the first day of capecitabine treatment and had a minimum follow-up of 3 cycles. One hand/foot of each patient constituted the study hand/foot, whereas the others constituted the control. Henna was administered to the study hand/foot on the first day of treatment and application renewed weekly. Development of grade 1–3 toxicity was set as the termination criterion for study. RESULTS: Painful skin changes such as rawness, intumescence and bulla formation, blocking the daily activities or self-care were observed in 26.9% of the patients in the 3rd or 4th cycles of treatment. Development time and severity of skin changes over time did not differ significantly between the study and the control hand/foot. CONCLUSION: Further studies with a larger sample size are needed to conclude on the prophylactic effect of henna in the management of the HFS. Cite this article as: Kayikci, E. E., Can, G., Sen, F., Saip, P. (2020). Henna application in the prevention of capecitabine-induced hand-foot syndrome in breast and colorectal cancer patients. Florence Nightingale Journal of Nursing, 28(3), 299-311.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kayıkçı et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: